Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$419M |
| 2 |
Truist Financial
TFC
|
+$351M |
| 3 |
Mastercard
MA
|
+$218M |
| 4 |
PPL
PPL Corp
PPL
|
+$193M |
| 5 |
Cognizant
CTSH
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$592M |
| 2 |
IBM
IBM
|
+$320M |
| 3 |
Wells Fargo
WFC
|
+$306M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$290M |
| 5 |
Walt Disney
DIS
|
+$267M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.85% |
| 2 | Financials | 13.92% |
| 3 | Healthcare | 13.77% |
| 4 | Consumer Discretionary | 10.1% |
| 5 | Industrials | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Calix
CALX
$2.51B
| $1.36M | ﹤0.01% |
170,400
+4,535
| +3% | +$33.8K |
|
3002
American Superconductor
AMSC
$1.53B
| $1.36M | ﹤0.01% |
173,000
-260
| -0.2% | -$2.09K |
|
3003
eGain
EGAN
$200M
| $1.36M | ﹤0.01% |
171,169
+12,476
| +8% | +$96.5K |
|
3004
State Street SPDR S&P 500 Fossil Fuel Reserves Free ETF
SPYX
$2.89B
| $1.36M | ﹤0.01% |
51,570
+28,320
| +122% | +$713K |
|
3005
StoneCo
STNE
$2.49B
| $1.35M | ﹤0.01% |
33,777
+24,748
| +274% | +$905K |
|
3006
Inseego
INSG
$82.6M
| $1.34M | ﹤0.01% |
18,344
+2,289
| +14% | +$132K |
|
3007
Titan Machinery
TITN
$431M
| $1.34M | ﹤0.01% |
90,477
+12,257
| +16% | +$191K |
|
3008
Covenant Logistics
CVLG
$865M
| $1.34M | ﹤0.01% |
206,732
-5,464
| -3% | -$39.6K |
|
3009
Fidelity D&D Bancorp
FDBC
$322M
| $1.34M | ﹤0.01% |
21,481
+905
| +4% | +$58.8K |
|
|
PAMT
3010
PAMT Corp
PAMT
$279M
| $1.33M | ﹤0.01% |
92,452
-32,472
| -26% | -$473K |
|
|
EVBN
3011
DELISTED
Evans Bancorp Inc
EVBN
| $1.33M | ﹤0.01% |
33,231
+13,090
| +65% | +$510K |
|
3012
Vanguard Russell 2000 ETF
VTWO
$17.5B
| $1.33M | ﹤0.01% |
20,008
| – | – |
|
|
STXB
3013
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
| $1.33M | ﹤0.01% |
57,895
+7,462
| +15% | +$164K |
|
|
WBII
3014
DELISTED
WBI BullBear Global Income ETF
WBII
| $1.33M | ﹤0.01% |
52,153
-1,137
| -2% | -$28.8K |
|
|
RUBY
3015
DELISTED
Rubius Therapeutics, Inc
RUBY
| $1.33M | ﹤0.01% |
139,785
+14,530
| +12% | +$141K |
|
|
PFNX
3016
DELISTED
Pfenex Inc.
PFNX
| $1.32M | ﹤0.01% |
120,680
+21,241
| +21% | +$211K |
|
3017
ING
ING
$102B
| $1.32M | ﹤0.01% |
109,634
+33,213
| +43% | +$380K |
|
3018
Luxfer Holdings
LXFR
$457M
| $1.32M | ﹤0.01% |
71,211
+3,333
| +5% | +$57.4K |
|
3019
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $1.32M | ﹤0.01% |
13,854
-1,926
| -12% | -$167K |
|
3020
iShares Silver Trust
SLV
$31.3B
| $1.31M | ﹤0.01% |
78,485
-569
| -0.7% | -$9.22K |
|
3021
iRadimed
IRMD
$1.11B
| $1.31M | ﹤0.01% |
55,892
+3,869
| +7% | +$90.4K |
|
|
NPTN
3022
DELISTED
NEOPHOTONICS CORP
NPTN
| $1.31M | ﹤0.01% |
148,085
+4,178
| +3% | +$31.3K |
|
3023
Lennar Class B
LEN.B
$20.1B
| $1.3M | ﹤0.01% |
30,490
-673
| -2% | -$29.9K |
|
3024
PIMCO Dynamic Income Fund
PDI
$7.33B
| $1.29M | ﹤0.01% |
39,884
+4,736
| +13% | +$156K |
|
3025
iShares MSCI Turkey ETF
TUR
$220M
| $1.29M | ﹤0.01% |
47,743
-3,059
| -6% | -$79K |
|
Similar funds
Bank of New York Mellon's Q4 2019 Portfolio in Review
As of Q4 2019, Bank of New York Mellon held 4,341 positions worth $388B, up 6.4% from $364B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Bank of New York Mellon's Q4 2019 filing shows 131 new, 1,843 increased, 1,854 reduced and 165 closed positions. Its largest new stake was State Street SPDR Bloomberg Emerging Markets Local Bond ETF: 1,648,268 shares worth $46M. The largest sale was Celgene Corp, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Bank of New York Mellon's largest Q4 2019 buy was State Street SPDR Bloomberg Emerging Markets Local Bond ETF: 1,648,268 shares worth $46M.
- Bank of New York Mellon added most to Bristol-Myers Squibb in Q4 2019, an estimated $419M increase.
- Bank of New York Mellon's biggest Q4 2019 reduction was IBM, cutting an estimated $320M.
- Bank of New York Mellon fully exited Celgene Corp in Q4 2019, selling an estimated $592M.
- Bank of New York Mellon's ten largest holdings make up 16% of its $388B portfolio in Q4 2019.
- Bank of New York Mellon opened 131 new positions and closed 165 in Q4 2019.
- Bank of New York Mellon's portfolio value rose 6.4% quarter-over-quarter to $388B.
Based on Bank of New York Mellon's 13F filing for Q4 2019, filed 14 Feb 2020.